Stocks
Keryx Biopharmaceuticals, Inc.KERX
NASDAQHealthcareBiotechnology$3.36+0.00%
A biotechnology company focused on treatments for kidney disease, the firm developed and commercialized Auryxia (ferric citrate), a drug used to manage phosphate levels and iron deficiency in patients with chronic kidney disease. Its strategy centered on specialty pharmaceuticals for nephrology, wit...
Market Cap: $052W Range: $2.47 – $5.98
Congressional Interest in Keryx Biopharmaceuticals, Inc. (KERX)
3 members of Congress have disclosed 6 trades in Keryx Biopharmaceuticals, Inc. (KERX), a Healthcare company. The buy/sell breakdown shows 4 purchases versus 2 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
6
Unique Politicians
3
Buys
4
Sells
2
Who in Congress Is Trading KERX?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-02-10 | DEBBIE WASSERMAN SCHULTZ | buy | $1K – $15K |
| 2016-12-12 | DEBBIE WASSERMAN SCHULTZ | buy | $1K – $15K |